Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
VHT
410
HOLDINGS
4%
ALSO IN PPH
PPH
27
HOLDINGS
67%
ALSO IN VHT
SECTOR DRIFT (VHT minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.1% | 22.3% | 14.1% |
|
MERCK & CO. INC. | 4.7% | 9.5% | 4.7% |
|
ABBVIE INC | 6.1% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 8.5% | 4.0% | 4.0% |
|
PFIZER INC | 2.4% | 4.8% | 2.4% |
VHT Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 5.5% |
|
JOHNSON & JOHNSON | 4.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
AMGEN INC | 2.9% |
|
GILEAD SCIENCES INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.4% |
|
ABBOTT LABORATORIES | 2.4% |
|
ABBVIE INC | 2.0% |
|
DANAHER CORP | 1.8% |
|
CVS CAREMARK CORP | 1.8% |
VHT Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.5% |
|
ELI LILLY & CO | -8.3% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.9% |
|
MERCK & CO. INC. | -4.8% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.2% |
|
ASTRAZENECA PLC-SPONS ADR | -4.1% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |